ETRGF

Entourage Health Corp carries a Neutral rating, supported by a 42 composite score and low conviction of two out of five. Regulatory is the strongest pillar at 58, reflecting an 80 jurisdiction-posture subscore and an 80 enforcement subscore. Market contributes 40, although institutional pricing feeds provide no available quote, limiting confirmation from trading behavior. Fundamentals score 37 as modest top-line expansion is outweighed by weak profitability, a small market capitalization tier, and limited cash-runway support. Editorial ranks last at 30, with no newsroom or brief activity in CIN newsroom coverage. The resulting profile sits firmly within the Neutral band: regulatory standing provides stability, while financial strain and sparse market and editorial signals constrain a more constructive rating.

Licensed fundamentals data show year-over-year revenue growth of 9.1%, earning a 59.1 revenue-growth subscore. That expansion fails to translate into attractive economics. Gross margin stands near 10.2%, corresponding to a 17 gross-margin subscore, while operating margin is negative 12.2%. Net income records a loss of approximately $42.2 million, and EBITDA remains negative at about $15.1 million. The cash-burn ratio exceeds 12 times, cash runway scores 15, and the financial condition remains stretched. Regulatory cadence is also incomplete: primary regulatory filings show no dated latest filing, no reported events across the latest 90- or 180-day periods, and no enforcement hits. The absence of enforcement activity supports the regulatory pillar, but the 25 cadence subscore prevents that pillar from carrying greater weight.

The principal forward catalyst rests with regulatory, the highest-scoring pillar. Canada’s favorable jurisdiction posture and the clean enforcement record establish the strongest base in the framework, while renewed filing activity offers the clearest path to strengthening the overall profile. A current primary regulatory filing would improve visibility into operations, validate the reporting sequence, and help close the gap between the 80-point jurisdiction and enforcement drivers and the 25-point cadence measure. The single most important signal to watch is the appearance of a current, dated primary regulatory filing.